Literature DB >> 3422694

Simplifying infusion chemotherapy: preliminary communication.

S R Ebbs1, J A Saunders, J V Roberts, M Baum, T Bates, J E Morris.   

Abstract

A low-intervention policy for Hickman catheter maintenance has been evaluated and found to be safe and cost effective. A simple, lightweight, disposable device has been used for 24-hour ambulatory home infusion. Implementation of this policy as part of a prospective randomized trial of single-agent chemotherapy in advanced breast cancer has demonstrated that slow intravenous infusion reduces the acute toxicity of epirubicin when compared with bolus injection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422694      PMCID: PMC1291419          DOI: 10.1177/014107688808100107

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  3 in total

Review 1.  Continuous infusion or bolus injection in cancer chemotherapy.

Authors:  R W Carlson; B I Sikic
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

2.  Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.

Authors:  W G Jones; W Mattsson
Journal:  Cancer Treat Rep       Date:  1984-04

3.  A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.

Authors:  K K Jain; E S Casper; N L Geller; T B Hakes; R J Kaufman; V Currie; W Schwartz; C Cassidy; G R Petroni; C W Young
Journal:  J Clin Oncol       Date:  1985-06       Impact factor: 44.544

  3 in total
  1 in total

Review 1.  Advances in epigenetics link genetics to the environment and disease.

Authors:  Giacomo Cavalli; Edith Heard
Journal:  Nature       Date:  2019-07-24       Impact factor: 49.962

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.